Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Biomea Fusion, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +4 vs. Q4 2023
- Shares held
- 31.2M
- +3.27M (+11.7%) vs. Q4 2023
- Total value
- $465.9M
- +$60.8M (+15.0%) vs. Q4 2023
- New holders
- 19
- 31 more added
- Sold out
- 15
- 30 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $36.8M |
| Q1 2026 | 65 | $37.2M |
| Q4 2025 | 60 | $28.8M |
| Q3 2025 | 73 | $50.6M |
| Q2 2025 | 87 | $51.7M |
| Q1 2025 | 95 | $45.0M |
| Q4 2024 | 108 | $89.3M |
| Q3 2024 | 88 | $236.7M |
| Q2 2024 | 107 | $106.1M |
| Q1 2024 | 104 | $465.9M |
| Q4 2023 | 100 | $405.1M |
| Q3 2023 | 85 | $414.5M |
| Q2 2023 | 90 | $649.4M |
| Q1 2023 | 73 | $727.0M |
| Q4 2022 | 55 | $122.0M |
| Q3 2022 | 50 | $144.5M |
| Q2 2022 | 42 | $204.0M |
| Q1 2022 | 50 | $81.2M |
| Q4 2021 | 49 | $127.3M |
| Q3 2021 | 39 | $204.5M |
| Q2 2021 | 44 | $253.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Biomea Fusion, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 2,720,983 | $40.7M | 1.13% | −15,384−0.6% | Reduced |
| Cormorant Asset Management, LP | 3,570,872 | $53.4M | 2.35% | 00.0% | Unchanged |
| State Street Corp | 4,485,615 | $67.1M | 0.00% | +3,134,667+232.0% | Added |
| FMR LLC | 5,355,867 | $80.1M | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −110,377−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −90,756−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −59,700−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −54,791−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −52,994−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −42,950−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −26,817−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −15,792−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −13,356−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −11,206−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −7,014−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −3,715−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |